Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-096485
Filing Date
2011-11-08
Accepted
2011-11-08 16:13:05
Documents
8
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c24235e10vq.htm 10-Q 210122
2 EX-31.1 SECTION 302 CERTIFICATION OF THE CEO & CFO c24235exv31w1.htm EX-31.1 5864
3 EX-32.1 SECTION 906 CERTIFICATION OF THE CEO & CFO c24235exv32w1.htm EX-32.1 2508
  Complete submission text file 0000950123-11-096485.txt   1126644

Data Files

Seq Description Document Type Size
4 EX-101 INSTANCE DOCUMENT inhx-20110930.xml EX-101.INS 112365
5 EX-101 SCHEMA DOCUMENT inhx-20110930.xsd EX-101.SCH 8093
6 EX-101 CALCULATION LINKBASE DOCUMENT inhx-20110930_cal.xml EX-101.CAL 27225
7 EX-101 LABELS LINKBASE DOCUMENT inhx-20110930_lab.xml EX-101.LAB 94793
8 EX-101 PRESENTATION LINKBASE DOCUMENT inhx-20110930_pre.xml EX-101.PRE 59364
Mailing Address 9005 WESTSIDE PARKWAY ALPHARETTA GA 30004
Business Address 9005 WESTSIDE PARKWAY ALPHARETTA GA 30004 678-746-1100
INHIBITEX, INC. (Filer) CIK: 0001274913 (see all company filings)

EIN.: 742708737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50772 | Film No.: 111187982
SIC: 2836 Biological Products, (No Diagnostic Substances)